Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

BioMarin's real world data sways NICE on orphan drug Vimizim

BioMarin's real world data sways NICE on orphan drug Vimizim Rare genetic disorder treatment recommended in final draft guidance. NICE has issued final draft guidance recommending BioMarin Pharma's Vimizim (elosulfase alfa) for the treatment of the rare genetic disorder Morquio

Pharma deals in August 2015

Pharma deals in August 2015 Licence. 700. BioMarin. Medivation. Talazoparib a PARP inhibitor in P3 for BRCA mutated breast cancer.

Amgen beats Sanofi to PCSK9 inhibitor market

Amgen beats Sanofi to PCSK9 inhibitor market first to launch in the US after buying a priority review voucher from BioMarin last year.

BioMarin drug boosts growth in children with dwarfism

BioMarin drug boosts growth in children with dwarfism Vosoritide showed results in 50% of trial participants. A drug in development at BioMarin has increased growth rates in children with dwarfism in 50%, raising hopes for the first effective therapy ... BioMarin is a rare disease specialist and already

Praluent and Repatha backed for approval in US

Praluent and Repatha backed for approval in US The FDA's review date for Praluent is July 24 - accelerated thanks to Sanofi's purchase of a priority review voucher from BioMarin last year - while the agency is due to

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...
MIT reveals new pill to deliver insulin
A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team...
Fearless Girl cover
25 Women Leaders in UK Healthcare
Women trailblazers helping to shape the future of healthcare (Part 1)...

Infographics